Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Apr 21;6(4):e18505.
doi: 10.1371/journal.pone.0018505.

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects

Affiliations
Randomized Controlled Trial

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects

Jessica E Haberer et al. PLoS One. .

Abstract

Introduction: A better understanding of pediatric antiretroviral therapy (ART) adherence in sub-Saharan Africa is necessary to develop interventions to sustain high levels of adherence.

Methodology/principal findings: Adherence among 96 HIV-infected Zambian children (median age 6, interquartile range [IQR] 2,9) initiating fixed-dose combination ART was measured prospectively (median 23 months; IQR 20,26) with caregiver report, clinic and unannounced home-based pill counts, and medication event monitoring systems (MEMS). HIV-1 RNA was determined at 48 weeks. Child and caregiver characteristics, socio-demographic status, and treatment-related factors were assessed as predictors of adherence. Median adherence was 97.4% (IQR 96.1,98.4%) by visual analog scale, 94.8% (IQR 86,100%) by caregiver-reported last missed dose, 96.9% (IQR 94.5,98.2%) by clinic pill count, 93.4% (IQR 90.2,96.7%) by unannounced home-based pill count, and 94.8% (IQR 87.8,97.7%) by MEMS. At 48 weeks, 72.6% of children had HIV-1 RNA <50 copies/ml. Agreement among adherence measures was poor; only MEMS was significantly associated with viral suppression (p = 0.013). Predictors of poor adherence included changing residence, school attendance, lack of HIV disclosure to children aged nine to 15 years, and increasing household income.

Conclusions/significance: Adherence among children taking fixed-dose combination ART in sub-Saharan Africa is high and sustained over two years. However, certain groups are at risk for treatment failure, including children with disrupted routines, no knowledge of their HIV diagnosis among older children, and relatively high household income, possibly reflecting greater social support in the setting of greater poverty.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Agreement between measures (as shown by the difference between methods versus mean adherence value for each child).
The Bland-Altman plots in this figure show pair wise agreement between adherence methods. Each plot indicates the difference between two methods on the vertical axis against the mean of the same methods on the horizontal axis. Data points above the zero line occur when the first method shows higher adherence than the second. On the horizontal axis, data points to the right indicate high adherence from both methods, in which case the maximum possible difference between them is shown by the angled lines.

References

    1. Report on the Global AIDS Epidemic. Joint United Nations Programme on AIDS. 2009. Available at: http://www.unaids.org/en/KnowledgeCentre/ HIVData/GlobalReport/2008/2008_global_report.asp.
    1. Children and AIDS Fourth Stocktaking Report. UNICEF. 2009. Available at: http://www.unicef.org/colombia/pdf/Children_and_AIDS_A_FSR_LoRes_PDF_EN_....
    1. Burns DN, Mofenson L. Paediatric HIV-1 infection. Lancet. 1999;354:1–6. - PubMed
    1. de Martino M, Tovo PA, Balducci M, Galli L, Gabiano C, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000;284:190–197. - PubMed
    1. Flynn PM, Rudy BJ, Douglas SD, Lathey J, Spector SA, et al. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis. 2004;190:271–279. - PubMed

Publication types

Substances